Novavax’s COVID-19 Vaccine Approved in Britain for use as Booster

0
113

https://healthwise.punchng.com/novavaxs-covid-19-vaccine-approved-in-britain-for-use-as-booster/Britain’s medicines regulator has approved Novavax’s Nuvaxovid vaccine as a COVID-19 booster for adults 18 and older, the U.S-based biotech company said on Wednesday.

Novavax Inc said that the Medicines and Healthcare Products Regulatory Agency has expanded the conditional marketing authorization for Nuvaxovid as a booster dose following a primary series of shots.

Nuvaxovid is also available for use as a booster in adults aged 18 and older in the US, European Union, Japan, Australia, New Zealand, Switzerland, and Israel.

The MHRA previously granted conditional marketing authorization for Nuvaxovid as a primary series in adults aged 18 and older in February 2022, and in adolescents aged 12 through 17 in August 2022.

See also  875 People Commit Suicide During Coronavirus Lockdown in Nepal

(DPA/NAN)

LEAVE A REPLY

Please enter your comment!
Please enter your name here